Obesity Trials in Changzhou, China
Conditions / Obesity / Changzhou, China
Obesity is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06066528 | A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight | COMPLETED | — |
| NCT06077864 | A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) | ACTIVE_NOT_RECRUITING | — |
| NCT06214741 | A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight | COMPLETED | — |
| NCT04251156 | Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity. | COMPLETED | PHASE3 |
| NCT03720574 | Lorcaserin and Behavioral Modification for Overweight and Obesity Management in Chinese Obese Patients | TERMINATED | PHASE3 |
| NCT05890976 | Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3) | COMPLETED | PHASE3 |
| NCT07037459 | Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity | RECRUITING | — |
| NCT06066515 | A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight | COMPLETED | PHASE3 |
| NCT06041217 | A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range | COMPLETED | PHASE3 |
| NCT05024032 | A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN) | COMPLETED | PHASE3 |